UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 172

Sortiert nach

Guidelines for treatment of autoimmune neuromuscular transmission disorders

European journal of neurology, 2010-07, Vol.17 (7), p.893-902

2010

Volltextzugriff (PDF)

EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia

European journal of neurology, 2010-06, Vol.17 (6), p.767-773

2010

Volltextzugriff (PDF)

Bending over forwards - to make a diagnosis

European journal of neurology, 2016-06, Vol.23 (6), p.993-994

Hilton-Jones, D.

2016

Volltextzugriff (PDF)

Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients

Neurology, 2012-05, Vol.78 (20), p.1601

2012

Volltextzugriff (PDF)

The myotonic dystrophies: diagnosis and management

Journal of Neurology, Neurosurgery and Psychiatry, 2010-04, Vol.81 (4), p.358-367

2010

Volltextzugriff (PDF)

Longitudinal observational study of sporadic inclusion body myositis: Implications for clinical trials

Neuromuscular disorders : NMD, 2013-05, Vol.23 (5), p.404-412

2013

Volltextzugriff (PDF)

Mutational spectrum and phenotypic variability of VCP-related neurological disease in the UK

Journal of neurology, neurosurgery and psychiatry, 2016-06, Vol.87 (6), p.680-681

2016

Volltextzugriff (PDF)

Guidelines for the treatment of autoimmune neuromuscular transmission disorders

European journal of neurology, 2006-07, Vol.13 (7), p.691-699

2006

Volltextzugriff (PDF)

Treatment resistance in inclusion body myositis: the role of mast cells

Neuromuscular disorders : NMD, 2024-08, Vol.41, p.20-23

2024

Volltextzugriff (PDF)

Long-term observational study of sporadic inclusion body myositis

Brain (London, England : 1878), 2011-11, Vol.134 (11), p.3176-3184

2011

Volltextzugriff (PDF)

EFNS review on the role of muscle biopsy in the investigation of myalgia

European journal of neurology, 2013-07, Vol.20 (7), p.997-1005

2013

Volltextzugriff (PDF)

Drug-induced myopathies in adults

Neuromuscular disorders : NMD, 2016-10, Vol.26, p.S151-S151

Hilton-Jones, D

2016

Volltextzugriff (PDF)

Statins and myopathies

Journal of the neurological sciences, 2015-10, Vol.357, p.e476-e476

Hilton-Jones, D

2015

Volltextzugriff (PDF)

Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes

Neurology, 2003-09, Vol.61 (6), p.826

2003

Volltextzugriff (PDF)

Myasthenia in pregnancy: best practice guidelines from a UK multispecialty working group

Journal of neurology, neurosurgery and psychiatry, 2014-05, Vol.85 (5), p.538-543

2014

Volltextzugriff (PDF)

The use of rituximab in myasthenia gravis and Lambert–Eaton myasthenic syndrome

Journal of neurology, neurosurgery and psychiatry, 2011-06, Vol.82 (6), p.671-673

2011

Volltextzugriff (PDF)

Myotonic dystrophy: practical issues relating to assessment of strength

Journal of neurology, neurosurgery and psychiatry, 2006-11, Vol.77 (11), p.1282-1283

2006

Volltextzugriff (PDF)

Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008

Neuromuscular disorders : NMD, 2010-02, Vol.20 (2), p.142-147

2010

Volltextzugriff (PDF)

Myotonic dystrophy: diagnosis, management and new therapies

Current opinion in neurology, 2014-10, Vol.27 (5), p.599-606

2014

Volltextzugriff (PDF)

213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18–20 September 2015

Neuromuscular disorders : NMD, 2016-08, Vol.26 (8), p.523-534

2016

Volltextzugriff (PDF)

MRC Centre for Neuromuscular Diseases 1st (1st December 2010), and 2nd (2nd May 2012) myotonic dystrophy workshops, London, UK and the myotonic dystrophy standards of care and national registry meeting, Newcastle, UK July 2011

Neuromuscular disorders : NMD, 2013-12, Vol.23 (12), p.1069-1080

2013

Volltextzugriff (PDF)

Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1 – The patients’ perspective

Neuromuscular disorders : NMD, 2012-07, Vol.22 (7), p.597-603

2012

Volltextzugriff (PDF)

Mitochondrial disease and lipid storage myopathy due to mutation in CHCHD10 or DNM1L and disordered mitochondrial dynamics

Neuromuscular disorders : NMD, 2017-03, Vol.27, p.S21-S21

2017

Volltextzugriff (PDF)

Fracture rate in patients with myasthenia gravis: the general practice research database

Osteoporosis international, 2013-02, Vol.24 (2), p.467-476

2013

Volltextzugriff (PDF)

Paediatric autoimmune myasthenia gravis: Any prognostic factor for disease remission?

European journal of paediatric neurology, 2017-06, Vol.21, p.e233-e234

2017

Volltextzugriff (PDF)

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(164)
Mit Volltextzugriff
(159)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(90)
Life Sciences & Biomedicine
(86)
Science & Technology
(86)
Neurology
(57)
Clinical Neurology
(56)
Neurosciences & Neurology
(56)
Adult
(52)
Female
(52)
Male
(47)
Biological And Medical Sciences
(36)
Middle Aged
(35)
Medical Sciences
(34)
Neurosciences
(33)
Aged
(23)
Adolescent
(20)
Diseases Of Striated Muscles. Neuromuscular Diseases
(20)
Psychiatry
(16)
Surgery
(15)
Child
(14)
Medicin Och Hälsovetenskap
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Guidelines for treatment of autoimmune neuromuscular transmission disorders

EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia

Bending over forwards - to make a diagnosis

Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients

The myotonic dystrophies: diagnosis and management

Longitudinal observational study of sporadic inclusion body myositis: Implications for clinical trials

Mutational spectrum and phenotypic variability of VCP-related neurological disease in the UK

Guidelines for the treatment of autoimmune neuromuscular transmission disorders

Treatment resistance in inclusion body myositis: the role of mast cells

Long-term observational study of sporadic inclusion body myositis

EFNS review on the role of muscle biopsy in the investigation of myalgia

Drug-induced myopathies in adults

Statins and myopathies

Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes

Myasthenia in pregnancy: best practice guidelines from a UK multispecialty working group

The use of rituximab in myasthenia gravis and Lambert–Eaton myasthenic syndrome

Myotonic dystrophy: practical issues relating to assessment of strength

Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008

Myotonic dystrophy: diagnosis, management and new therapies

213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18–20 September 2015

MRC Centre for Neuromuscular Diseases 1st (1st December 2010), and 2nd (2nd May 2012) myotonic dystrophy workshops, London, UK and the myotonic dystrophy standards of care and national registry meeting, Newcastle, UK July 2011

Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1 – The patients’ perspective

Mitochondrial disease and lipid storage myopathy due to mutation in CHCHD10 or DNM1L and disordered mitochondrial dynamics

Fracture rate in patients with myasthenia gravis: the general practice research database

Paediatric autoimmune myasthenia gravis: Any prognostic factor for disease remission?

Suchergebnisse filtern